pharmaceuticals
Repeal of LIFO (last in, first out) H.R. 471 & S. 483 - Ensuring Patient Access and Effective Drug Enforcement Act - all provisions S. 506/H.R. 696(Medicare Prompt Pay Discount Exclusion), legislation to ensure more appropriate general payment amount for drugs and biologics under Part B of the Medicare Program by excluding customary prompt-pay discounts extended to wholesalers from the manufacturer's average sales price. Average Sales Price (ASP), generally including CMS' proposed Part B Drug payment demonstration rule. Sequestration cuts to cancer care.
 H.R. 1416 (Cancer Patient Protection Act of 2013) legislation to exclude cancer drugs from sequestration cuts.
TAX - Taxation/Internal Revenue Code HCR - Health Issues MMM - Medicare/Medicaid
2 - HOUSE OF REPRESENTATIVES 1 - SENATE 2 - HOUSE OF REPRESENTATIVES 1 - SENATE 2 - HOUSE OF REPRESENTATIVES 1 - SENATE
ROBERTI GLOBAL (F/K/A ROBERTI WHITE, LLC)
900 G Street NW, Suite 301, Washington, DC, 20001, US
STEVEN E IRIZARRY STEVEN E IRIZARRY VINCENT A. ROBERTI, SR. STEVEN E IRIZARRY VINCENT A. ROBERTI, SR.